Biocon founder and chairperson Kiran
Mazumdar-Shaw plans a gradual leadership transition over the
next five years, with her niece Claire Mazumdar expected to take
over as chair in a phased manner, she said on Tuesday.
Claire Mazumdar is the founding chief executive of Bicara
Therapeutics, an oncology-focused biotech firm
incubated with early backing from Kiran Mazumdar-Shaw.
“I am not hanging up my boots anytime soon, but I want
Claire to succeed me in a very phased manner,” Mazumdar-Shaw
told Reuters in a phone interview, adding that the succession
would involve a step-by-step transition from director to
vice-chair and eventually chair.
Before founding Bicara, Claire led business development and
corporate strategy at Rheos Medicines and worked at Third Rock
Ventures, where she focused on company formation and
partnerships.
The succession plan was first reported by business magazine
Fortune India in an interview with Mazumdar-Shaw.